Amedica Co. (NASDAQ:AMDA) shares reached a new 52-week low on Tuesday . The stock traded as low as $1.99 and last traded at $1.98, with a volume of 103968 shares traded. The stock had previously closed at $2.08.
AMDA has been the topic of several analyst reports. ValuEngine upgraded shares of Amedica from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd. Maxim Group restated a “hold” rating on shares of Amedica in a report on Wednesday, January 24th. Finally, Ladenburg Thalmann Financial Services cut shares of Amedica from a “buy” rating to a “neutral” rating in a report on Monday, November 27th.
A hedge fund recently raised its stake in Amedica stock. Vanguard Group Inc. boosted its stake in Amedica Co. (NASDAQ:AMDA) by 7.1% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 595,866 shares of the medical equipment provider’s stock after acquiring an additional 39,603 shares during the period. Vanguard Group Inc. owned 2.26% of Amedica worth $226,000 as of its most recent filing with the SEC. 5.62% of the stock is currently owned by institutional investors and hedge funds.
Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty.
Receive News & Ratings for Amedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedica and related companies with MarketBeat.com's FREE daily email newsletter.